Clinical Trial Update: α-N-acetylgalactosaminidase in Methamphetamine Psychosis

View source ↗

Summary

The clinical trial assessing α-N-acetylgalactosaminidase for methamphetamine use disorder and methamphetamine-induced psychosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder
• Methamphetamine-induced Psychosis

Drugs mentioned

• α-N-acetylgalactosaminidase (alpha-N-acetylgalactosaminidase)

Snippet

Sponsor: Elazığ Mental Health and Diseases Hospital | Conditions: Methamphetamine Use Disorder, Methamphetamine-induced Psychosis | Status: COMPLETED